ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair regrowth product for FDA registration status approval. The FDA registration process should be relatively quick, and we expect this process to be completed within a few weeks.
Related news for (VDRM)
- ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance
- ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India
- ViaDerma Announces Significant 2024 Achievements and International Expansion
- ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More